---
document_datetime: 2023-09-21 21:13:43
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/nexpovio-epar-all-authorised-presentations_en.pdf
document_name: nexpovio-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0527944
conversion_datetime: 2025-12-15 00:46:01.279883
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented)   | Strength   | Pharmaceutical     | Route of       | Immediate Packaging     | Pack size   |
|------------------|--------------|------------|--------------------|----------------|-------------------------|-------------|
|                  | name         |            | Form               | Administration |                         |             |
| EU/1/21/1537/001 | Nexpovio     | 20 mg      | Film-coated tablet | Oral use       | blister (PVC/PCTFE/PVC) | 12 tablets  |
| EU/1/21/1537/002 | Nexpovio     | 20 mg      | Film-coated tablet | Oral use       | blister (PVC/PCTFE/PVC) | 16 tablets  |
| EU/1/21/1537/003 | Nexpovio     | 20 mg      | Film-coated tablet | Oral use       | blister (PVC/PCTFE/PVC) | 20 tablets  |
| EU/1/21/1537/004 | Nexpovio     | 20 mg      | Film-coated tablet | Oral use       | blister (PVC/PCTFE/PVC) | 32 tablets  |
| EU/1/21/1537/005 | Nexpovio     | 20 mg      | Film-coated tablet | Oral use       | blister (PVC/PCTFE/PVC) | 8 tablets   |